Halozyme Therapeutics Inc (HALO)

Exchange
NASDAQ
Symbol
HALO
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company is headquartered in San Diego, California.
Country
USA

Stock price

At close: October 3, 2024

  • Open
    58.12
  • High
    62.00
  • Low
    57.63
  • Close
    60.43
  • Volume
    1,857,640

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
3.31
Receivables turnover
—
Payables turnover
35.73
Working capital turnover
1.28
Days of inventory on hand (DOH)
110.31
Days of sales outstanding (DSO)
—
Number of days of payables
10.21
Fixed asset turnover
21.27
Total asset turnover
0.47
 Liquidity ratios
Current ratio
6.64
Quick ratio
2.99
Cash ratio
2.99
Cash conversion cycle
100.09
 Solvency ratios
Debt-to-assets ratio
0.86
Debt-to-capital ratio
0.95
Debt-to-equity ratio
17.89
Financial leverage ratio
20.68
Interest coverage
19.56
 Profitability ratios
Gross profit margin
47.90%
Operating profit margin
41.66%
Pretax margin
42.98%
Net profit margin
34.75%
Operating return on assets (Operating ROA)
19.48%
Return on assets (ROA)
16.25%
Return on total capital
23.19%
Return on equity (ROE)
336.00%